US health product giant Johnson and Johnson late Friday agreed to pay more for troubled medical device maker Guidant, raising its bid to for 68.5 billion dollars in the face of a competing offer from a Massachusetts based rival.
Johnson and Johnson agrees to pay more for Guidant.